Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
Cancers · 26.10.2023 · 15 (21) · 5148
DOI: 10.3390/cancers15215148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 26.10.2023. Verfasst von Lei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV 26505, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH NIGMS, NSF.
Abstract (Originalsprache)
Bone marrow mesenchymal stem cells (BM MSCs) play a tumor-supportive role in promoting drug resistance and disease relapse in multiple myeloma (MM). Recent studies have discovered a sub-population of MSCs, known as inflammatory MSCs (iMSCs), exclusive to the MM BM microenvironment and implicated in drug resistance. Through a sophisticated analysis of public expression data from unexpanded BM MSCs, we uncovered a positive association between iMSC signature expression and minimal residual disease. While in vitro expansion generally results in the loss of the iMSC signature, our meta-analysis of additional public expression data demonstrated that cytokine stimulation, including IL1-β and TNF-α, as well as immune cells such as neutrophils, macrophages, and MM cells, can reactivate the signature expression of iMSCs to varying extents. These findings underscore the importance and potential utility of cytokine stimulation in mimicking the gene expression signature of early passage of iMSCs for functional characterizations of their tumor-supportive roles in MM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV 26505, USA.
- Lane Department of Computer Science & Electrical Engineering, West Virginia University, Morgantown, WV 26506, USA.
- WVU Cancer Institute, West Virginia University, Morgantown, WV 26506, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morganton, WV 26506, USA.
ORCID-Profile: Lori A Hazlehurst, Gangqing Hu
Förderung
- NIGMS NIH HHS
- NIH NIGMS
- NSF
Zitieren
APA
Wang, L., Yi, W., Ma, L., Lecea, E., Hazlehurst, L. A., Adjeroh, D. A., & Hu, G. (2023). Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. Cancers, 15(21), 5148. https://doi.org/10.3390/cancers15215148
Vancouver
Wang L, Yi W, Ma L, Lecea E, Hazlehurst LA, Adjeroh DA, et al. Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. Cancers. 2023;15(21):5148. doi:10.3390/cancers15215148
BibTeX
@article{Wang2023,
author = {Wang, Lei and Yi, Weijun and Ma, Li and Lecea, Emily and Hazlehurst, Lori A and Adjeroh, Donald A and Hu, Gangqing},
title = {Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling},
journal = {Cancers},
year = {2023},
volume = {15},
number = {21},
pages = {5148},
doi = {10.3390/cancers15215148}
}
EUVIMED